Psychiatry

814 questions

Question 581Question →

A 45-year-old man comes to the clinic seeking help to stop drinking alcohol. He states, "I have been drinking half a liter of vodka daily for the past two years, but my wife says she will leave me if I don't quit." The patient's last drink was 5 days ago, and he successfully completed a supervised inpatient alcohol detoxification program yesterday. He feels "very depressed" about his marital problems and asks for a medication to help his mood as well as his alcohol cravings. His medical history is significant for bipolar I disorder, for which he has not taken any medications for several years, and severe osteoarthritis of the right knee. Current medications include a fentanyl transdermal patch for chronic pain. Vital signs are within normal limits. Physical examination reveals a palpable liver edge 3 cm below the right costal margin. Laboratory studies show an aspartate aminotransferase (AST) of 115 U/L, an alanine aminotransferase (ALT) of 52 U/L, and a serum creatinine of 0.8 mg/dL. Which of the following is the most appropriate pharmacotherapy to help maintain alcohol abstinence in this patient?

Show answer & explanation

Answer: Acamprosate

Answer

Acamprosate is the most appropriate medication to help maintain alcohol abstinence in this patient because it is safe to use with concurrent opioid therapy and in the setting of hepatic impairment.
Acamprosate is a first-line pharmacotherapy for Alcohol Use Disorder that acts via modulation of NMDA and GABA receptors to reduce cravings. It is excreted entirely by the kidneys and is safe to use in patients with hepatic impairment (such as this patient's alcoholic liver disease). Importantly, it does not interact with opioid medications, making it safe for this patient who is using a fentanyl patch for chronic pain.

Step-by-Step Solution

1
Identify the primary clinical goal.
The patient needs maintenance pharmacotherapy for Alcohol Use Disorder (AUD) to prevent relapse after successful detoxification.
First-line therapies for AUD maintenance include naltrexone and acamprosate. Second-line includes disulfiram.
2
Assess patient's comorbidities and current medications.
The patient uses a fentanyl transdermal patch, has untreated bipolar I disorder, and exhibits laboratory signs of alcoholic liver disease (AST:ALT ratio > 2:1).
Comorbidities and medication interactions dictate which AUD pharmacotherapy is safe to prescribe.
3
Evaluate contraindications for first-line AUD agents.
Naltrexone is contraindicated due to concurrent fentanyl use. Disulfiram is relatively contraindicated due to active liver disease. Sertraline is contraindicated due to unmedicated bipolar disorder.
Recognizing absolute and relative contraindications prevents dangerous adverse events like precipitated withdrawal, hepatotoxicity, or manic episodes.
4
Select the most appropriate and safe agent.
Acamprosate is selected.
Acamprosate is cleared renally (patient's creatinine is normal at 0.8 mg/dL), does not block opioid receptors, and is safe in liver disease.

Key Concept

Acamprosate is a first-line pharmacotherapy for Alcohol Use Disorder that is preferred in patients with significant liver disease or those who require concurrent opioid therapy, as it is renally excreted and does not block opioid receptors.
Question 582Question →

Match each patient's clinical presentation with the most appropriate, highly specific first-line behavioral or psychotherapeutic intervention.

Click a left item, then click its matching right item

Items

A 22-year-old who experiences severe bradycardia and syncope when witnessing venipuncture, seeking intervention before starting medical school.
A 30-year-old with recurrent, unexpected episodes of intense autonomic arousal and a persistent fear of future episodes, who prefers non-pharmacological treatment.
A 27-year-old with highly distressing, intrusive thoughts of accidentally causing a house fire, leading to hours of daily checking behavior, who declines medication.
A 35-year-old experiencing intense hyperarousal, intrusive memories, and avoidance behaviors that began 2 weeks after surviving a severe natural disaster.

Matches

Show answer & explanation

Answer

Blood-injection-injury phobia is matched with applied muscle tension therapy; Panic disorder is matched with CBT with interoceptive exposure; Obsessive-compulsive disorder is matched with exposure and response prevention; and Acute stress disorder is matched with trauma-focused CBT.
Each specific psychiatric diagnosis presented requires a highly targeted non-pharmacological intervention. BII phobia requires applied muscle tension to prevent syncope; panic disorder utilizes interoceptive exposure to break the fear response to somatic sensations; OCD relies on ERP to sever the link between obsession and compulsion; and ASD uses TF-CBT to process the acute trauma and prevent PTSD.

Step-by-Step Solution

1
Diagnose the 22-year-old patient experiencing syncope during venipuncture.
The diagnosis is specific phobia, blood-injection-injury type.
This specific phobia uniquely causes a vasovagal response, requiring applied muscle tension to elevate blood pressure and prevent fainting rather than traditional relaxation techniques.
2
Diagnose the 30-year-old patient with unexpected autonomic episodes and fear of future episodes.
The diagnosis is panic disorder.
The key non-pharmacological treatment for panic disorder is CBT utilizing interoceptive exposure to desensitize the patient to harmless physical sensations.
3
Diagnose the 27-year-old patient with intrusive thoughts and checking behaviors.
The diagnosis is obsessive-compulsive disorder.
The gold-standard psychotherapy for OCD is exposure and response prevention (ERP).
4
Diagnose the 35-year-old patient with trauma symptoms starting 2 weeks ago.
The diagnosis is acute stress disorder (ASD).
Because the trauma occurred less than 1 month ago, it is classified as ASD, not PTSD. The indicated treatment is trauma-focused CBT.

Key Concept

Selection of specific, evidence-based behavioral and psychotherapeutic interventions for anxiety, OCD, and trauma-related disorders.
Estimated Time:1m 30s
Question 583Question →

During morning rounds on the medical-surgical unit, a physician is urgently called to evaluate a 54-year-old male. The patient was admitted 48 hours ago for acute gallstone pancreatitis and has been managed with intravenous fluids and fasting. He has a 20-year history of consuming a pint of vodka daily, with his last drink occurring on the morning of admission. His home medications include phenelzine for treatment-resistant depression.

The nurse reports the patient suddenly became combative and is trying to pull out his intravenous lines. On evaluation, the patient is profoundly diaphoretic, tremulous, and disoriented to place and time. He is staring intently at the corner of the room, shouting, "The spiders are crawling out of the walls to get me!" His temperature is 38.9°C (102.0°F), blood pressure is 170/105 mm Hg, and pulse is 132/min.

When the physician approaches, the patient yells, "You are all trying to poison me! I am leaving right now!" and attempts to stumble out of the room. A review of his medical record indicates he has an advance directive naming his sister as his healthcare proxy, though he is currently married to an estranged wife.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Prevent the patient from leaving and administer intravenous lorazepam under the doctrine of emergency implied consent.

Answer

Prevent the patient from leaving and administer intravenous lorazepam under the doctrine of emergency implied consent.
The correct approach is to prevent the patient from leaving, using physical restraints if necessary, and immediately administer intravenous benzodiazepines (e.g., lorazepam). This patient is presenting with Delirium Tremens (DTs), a life-threatening complication of alcohol withdrawal characterized by autonomic instability, disorientation, and visual hallucinations typically occurring 48 to 96 hours after the last drink. Because DTs is a severe medical emergency and the patient is delirious (therefore lacking decision-making capacity), the physician must act under the principle of emergency implied consent. This ethical and legal principle allows life-saving treatment to be administered immediately to an incapacitated patient without requiring explicit surrogate authorization.

Step-by-Step Solution

1
Identify the primary clinical emergency.
The patient is experiencing Delirium Tremens (DTs), indicated by autonomic hyperactivity, visual hallucinations, and confusion 48 hours after alcohol cessation.
Accurate diagnosis differentiates a substance-induced medical emergency from a primary psychiatric disorder.
2
Assess the patient's decision-making capacity.
The patient lacks the capacity to refuse treatment or leave Against Medical Advice (AMA) due to his severe delirium and disorientation.
Capacity must be established to determine if a patient's refusal of care is legally binding.
3
Determine the appropriate legal pathway for intervention.
Apply the doctrine of emergency implied consent to administer life-saving treatment and prevent elopement.
In life-threatening medical emergencies where a patient lacks capacity, physicians are legally and ethically obligated to intervene immediately without delaying for surrogate consent.

Key Concept

Emergency implied consent allows physicians to treat patients who lack decision-making capacity in life-threatening medical emergencies (e.g., Delirium Tremens) without waiting for surrogate authorization.
Estimated Time:1m 30s
Question 584Question →

A 29-year-old woman, G1P0, at 28 weeks gestation is evaluated in the outpatient clinic due to worsening sadness and exhaustion. For the past six weeks, she has felt 'overwhelmed and hopeless,' crying daily. She reports profound despondency that is characteristically worse in the morning, complete loss of appetite, and terminal insomnia, waking up at 3:00 AM and unable to return to sleep. She recently developed an upper respiratory infection and frequently takes over-the-counter dextromethorphan for a persistent cough. Her physical examination is unremarkable. Laboratory studies show a hemoglobin level of 10.810.8 g/dL and a mean corpuscular volume of 8989 μ\mu m 3^3. She asks the physician to prescribe an antidepressant medication to help her cope. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Elicit a history regarding past periods of decreased need for sleep and unusually elevated energy

Answer

The most appropriate next step is to elicit a history regarding past periods of decreased need for sleep and unusually elevated energy.
The correct answer is to elicit a history regarding past periods of decreased need for sleep and unusually elevated energy. This patient is presenting with a major depressive episode with melancholic features. Before initiating any antidepressant therapy, it is mandatory to screen all patients for a history of manic or hypomanic episodes. Antidepressant monotherapy in a patient with undiagnosed bipolar disorder can precipitate a manic or hypomanic episode (manic switch). The peripartum period is a particularly high-risk timeframe for the onset or exacerbation of bipolar disorder.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient presents with symptoms of a major depressive episode with melancholic features during the peripartum period.
To establish the primary psychiatric syndrome requiring evaluation and intervention.
2
Identify the critical preliminary evaluation required before treating depression.
Before prescribing any antidepressant therapy, the patient must be screened for a history of mania or hypomania.
Antidepressants can trigger a manic switch in patients with underlying bipolar disorder. This is particularly crucial in the peripartum period, which is a high-risk time for bipolar affective episodes.
3
Evaluate the distracting options against the patient's history and laboratory values.
Options involving immediate antidepressant monotherapy without screening are incorrect. Furthermore, prescribing phenelzine risks a dangerous interaction with dextromethorphan, and treating her hemoglobin level of 10.810.8 g/dL is unnecessary as it reflects normal dilutional anemia of pregnancy.
To confidently eliminate incorrect management choices by applying pharmacological and physiological knowledge.

Key Concept

Screening for bipolar disorder is mandatory before initiating antidepressant therapy in patients presenting with a major depressive episode to prevent antidepressant-induced manic switch.
Question 585Question →

Paramedics transport a 41-year-old male accountant to the emergency department after his wife found him acutely confused and sweating profusely at home. The patient has a long-standing history of major depressive disorder that has been difficult to manage. Five days ago, his outpatient psychiatrist discontinued his fluoxetine and immediately initiated a prescription for phenelzine to target different neurotransmitter receptors. On examination, the patient is visibly shivering, highly agitated, and disoriented to time and place. Vital signs reveal a temperature of 39.5∘C39.5^\circ\text{C} (103.1∘F103.1^\circ\text{F}), blood pressure of 168/102 mm Hg168/102\text{ mm Hg}, and a heart rate of 124/min124\text{/min}. Neurological evaluation demonstrates dilated pupils, marked bilateral hyperreflexia in the lower extremities, and sustained ankle clonus. The medical team promptly discontinues all psychiatric medications and administers intravenous normal saline along with a dose of intravenous lorazepam. Thirty minutes later, the patient remains profoundly agitated, and his hyperthermia and clonus are completely unchanged. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer cyproheptadine

Answer

Administer cyproheptadine
The correct next step is to administer cyproheptadine. This patient is experiencing severe Serotonin Syndrome, precipitated by the premature initiation of an MAOI (phenelzine) immediately after discontinuing fluoxetine. Fluoxetine has a uniquely long half-life and requires a 5-week washout period before starting an MAOI to prevent this life-threatening drug interaction. The classic triad of Serotonin Syndrome includes altered mental status, autonomic hyperactivity, and neuromuscular abnormalities (specifically hyperreflexia and clonus, which distinguish it from NMS). Because the patient's symptoms (hyperthermia and agitation) failed to improve with standard initial therapy consisting of offending agent discontinuation, IV fluids, and benzodiazepines, targeted serotonin antagonism with cyproheptadine is strictly indicated.

Step-by-Step Solution

1
Identify the toxidrome based on the clinical presentation and medication history.
The combination of altered mental status, autonomic instability (hyperthermia, tachycardia, diaphoresis), and neuromuscular hyperactivity (hyperreflexia, sustained ankle clonus) strongly indicates Serotonin Syndrome.
The patient was transitioned from fluoxetine directly to an MAOI (phenelzine) without the mandatory 5-week washout period, leading to a massive accumulation of synaptic serotonin.
2
Evaluate the response to initial, first-line management interventions.
The patient received appropriate initial therapy (discontinuation of serotonergic agents, IV fluids, and IV benzodiazepines) but remained profoundly symptomatic and agitated.
While mild to moderate cases often resolve with supportive care and benzodiazepines alone, severe or refractory cases require targeted pharmacologic antagonism.
3
Select the specific pharmacologic antidote for the refractory condition.
Cyproheptadine should be administered.
Cyproheptadine is a first-generation histamine antagonist with strong serotonin (5-HT1A and 5-HT2A) antagonistic properties, making it the definitive next step for Serotonin Syndrome unresponsive to initial supportive measures.

Key Concept

Management of severe Serotonin Syndrome requires discontinuation of offending agents, supportive care with IV fluids and benzodiazepines, and administration of cyproheptadine for refractory symptoms.
Question 586Question →

A 27-year-old woman is evaluated in the outpatient psychiatry clinic for a 4-week history of profound sadness, excessive sleepiness, increased appetite, and severe difficulty concentrating at work. She states she has missed several days of work because she "cannot muster the energy to get out of bed." Two years ago, she experienced a 10-day period during which she slept only 2 hours per night, spoke very rapidly, spent her entire savings on a risky business venture, and was highly irritable. This past episode resulted in a brief psychiatric hospitalization. She is not currently taking any medications.

Physical examination shows normal vital signs. Mental status examination reveals psychomotor retardation, a blunted affect, and a depressed mood. Her thought process is linear, and she denies any suicidal ideation, delusions, or hallucinations.

Laboratory studies show:
- TSH: 1.8 µU/mL (normal: 0.5-5.0 µU/mL)
- Free T4: 1.2 ng/dL (normal: 0.8-1.8 ng/dL)
- Urine toxicology screen: negative

The physician decides to initiate pharmacotherapy for this patient's current episode. Which of the following medications are appropriate first-line monotherapy options for this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Quetiapine; Lurasidone

Answer

The appropriate first-line monotherapy options for this patient are Quetiapine and Lurasidone.
The correct options identify Quetiapine and Lurasidone as appropriate treatments. The patient's history of a severe manic episode (decreased sleep, rapid speech, risky behavior lasting 10 days and requiring hospitalization) establishes a diagnosis of Bipolar I Disorder. She is currently experiencing a major depressive episode. First-line monotherapy options for acute bipolar depression include specific second-generation antipsychotics (such as quetiapine, lurasidone, and cariprazine) and mood stabilizers (such as lithium). These medications effectively target depressive symptoms without precipitating a manic switch.

Step-by-Step Solution

1
Identify the primary diagnosis based on the patient's current presentation and past psychiatric history.
The patient is currently in a major depressive episode but has a clear history of a manic episode (decreased sleep, rapid speech, risky behavior lasting 10 days and requiring hospitalization), establishing a diagnosis of Bipolar I Disorder.
Accurate diagnosis is critical because the pharmacological management of bipolar depression differs significantly from that of unipolar major depressive disorder.
2
Select an appropriate first-line pharmacological agent for acute bipolar depression.
Quetiapine and Lurasidone are both first-line, FDA-approved monotherapy options for this condition.
Certain second-generation antipsychotics and mood stabilizers are efficacious for bipolar depression and stabilize mood without inducing manic episodes.
3
Exclude contraindicated medications and rule out secondary medical causes.
Sertraline and Venlafaxine are excluded due to the risk of manic switch. Levothyroxine is excluded because the patient's thyroid labs are entirely normal.
Antidepressant monotherapy is dangerous in Bipolar I Disorder. Normal thyroid function tests rule out hypothyroidism as a secondary cause of her depressive symptoms.

Key Concept

The treatment of acute bipolar depression requires mood stabilizers or specific second-generation antipsychotics (such as quetiapine or lurasidone). Antidepressant monotherapy (such as SSRIs or SNRIs) must be avoided due to the high risk of inducing a manic switch.
Estimated Time:1m 0s
Question 587Question →

A 27-year-old female medical resident presents to the clinic due to overwhelming anxiety. She reports experiencing intense palpitations, sweating, and hand tremors whenever she has to orally present patient cases during morning rounds. She states, 'I am terrified that my attendings will think I am incompetent because I look so nervous.' This anxiety is strictly isolated to public speaking; she has no difficulty interacting with patients, attending social events, or talking to colleagues in casual settings. Her past medical history is notable for asthma, which is currently managed with an albuterol inhaler as needed. Her vital signs are within normal limits. Which of the following is the most appropriate next step in management for this patient's psychiatric symptoms?

Show answer & explanation

Answer: Cognitive-behavioral therapy

Answer

Cognitive-behavioral therapy
The patient's symptoms of intense autonomic arousal (palpitations, sweating, tremors) occurring exclusively in the context of public speaking confirm a diagnosis of social anxiety disorder, performance-only subtype. The first-line treatments for this condition are as-needed beta-blockers (such as propranolol) or cognitive-behavioral therapy (CBT). Because this patient has a history of asthma, non-selective beta-blockers are contraindicated as they antagonize beta-2 receptors in the lungs, potentially causing severe bronchoconstriction. Therefore, cognitive-behavioral therapy is the safest and most appropriate next step in management.

Step-by-Step Solution

1
Diagnose the specific psychiatric condition based on the clinical presentation.
The patient has social anxiety disorder, performance-only subtype.
Her symptoms are strictly limited to public speaking and do not occur in general social situations.
2
Identify the standard first-line treatment options for this specific subtype.
First-line therapies include as-needed beta-blockers (e.g., propranolol) or cognitive-behavioral therapy (CBT).
These modalities specifically target the autonomic arousal and cognitive distortions associated with performance situations without requiring chronic daily medication.
3
Evaluate the patient's medical history for any absolute or relative contraindications to the standard therapies.
The patient has a history of asthma.
Non-selective beta-blockers like propranolol can cause severe bronchoconstriction and are contraindicated in asthmatics.
4
Select the most appropriate remaining management strategy.
Cognitive-behavioral therapy is chosen.
It is a highly effective first-line alternative that avoids the risk of bronchospasm associated with beta-blockers.

Key Concept

Management of performance-only social anxiety disorder in patients with medical contraindications to beta-blockers.
Question 588Question →

A 32-year-old woman with a severe opioid use disorder (primarily intravenous heroin) presents to an outpatient addiction clinic. She is highly motivated to achieve long-term abstinence and requests to start extended-release intramuscular naltrexone therapy, as her occupation makes daily medication adherence difficult. She used heroin this morning. Arrange the following clinical steps in the most appropriate chronological order for safely initiating extended-release naltrexone therapy in this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: complete medically supervised withdrawal, maintain 7 to 10 days of complete abstinence, obtain a confirmatory urine drug screen, perform a naloxone challenge test, and finally administer the extended-release naltrexone.
Naltrexone is a high-affinity competitive mu-opioid receptor antagonist used for relapse prevention in opioid use disorder. If administered to a patient who is physically dependent on opioids, it will abruptly displace the agonist, causing severe, rapid-onset precipitated withdrawal. Therefore, the standard of care requires complete opioid detoxification followed by a mandatory 7 to 10-day opioid-free period (up to 14 days for long-acting opioids like methadone). Objective evidence of abstinence is then obtained via urine drug screening. Because patient reporting and urine screens may not capture all synthetic opioids, a naloxone challenge (using a short-acting antagonist) is performed. If the challenge is negative (no withdrawal symptoms), the patient has no residual physiological dependence, and the long-acting intramuscular naltrexone can be safely administered.

Step-by-Step Solution

1
Identify the pharmacologic goal and mechanism.
The goal is to initiate naltrexone, a high-affinity pure mu-opioid receptor antagonist, in a patient currently dependent on a full agonist.
Understanding the mechanism highlights the severe risk of precipitated withdrawal if the antagonist is given prematurely.
2
Determine the initial requirement for transitioning.
The patient must first stop using opioids through a medically supervised withdrawal.
Naltrexone cannot be initiated while the patient is actively using opioids.
3
Establish the necessary waiting period.
A 7 to 10-day period of complete opioid abstinence must be maintained.
This allows physiological dependence to resolve and receptors to clear, distinguishing naltrexone induction from buprenorphine induction (which only requires mild withdrawal).
4
Verify readiness for naltrexone administration.
Obtain a negative urine drug screen, followed by a negative naloxone challenge test.
Objective testing prevents accidental severe precipitated withdrawal, and the short-acting naloxone challenge definitively rules out latent physiological dependence before giving a 30-day irreversible injection.

Key Concept

Initiation of extended-release naltrexone for opioid use disorder requires complete detoxification followed by a 7 to 10-day opioid-free period, confirmed by urine toxicology and a negative naloxone challenge test, to prevent severe precipitated withdrawal.
Question 589Question →

A 42-year-old high school teacher presents for evaluation of a 7-month history of difficulty initiating sleep and frequent, prolonged nocturnal awakenings. The patient reports spending over 9 hours in bed each night in a desperate attempt to feel rested, but estimates achieving only 4 to 5 hours of total sleep. The resulting severe daytime fatigue has begun to impair her teaching performance and daily functioning. She denies snoring, witnessed apneic events, or an urge to move her legs at rest. Physical examination, neurologic assessment, and routine laboratory studies are unremarkable.

Arrange the following clinical interventions in the most appropriate chronological sequence for the evidence-based, stepped-care management of this patient's condition, proceeding from initial assessment to subsequent escalations for refractory symptoms.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The chronological management of chronic insomnia begins with a sleep diary to establish baseline sleep efficiency, followed by Cognitive Behavioral Therapy for Insomnia (CBT-I) as the primary definitive treatment. If CBT-I is ineffective, a trial of a primary pharmacologic agent is initiated. If that initial agent fails, the patient should transition to a different medication class or undergo comprehensive reassessment for occult comorbidities.
The optimal management of chronic insomnia follows a strict evidence-based, stepped-care approach. First, a sleep diary is utilized to objectively document sleep patterns, calculate baseline sleep efficiency, and identify targets for behavioral modification. Second, Cognitive Behavioral Therapy for Insomnia (CBT-I) is initiated as the first-line definitive treatment, utilizing techniques like sleep restriction to consolidate the patient's highly fragmented sleep. Third, if CBT-I is insufficient, a trial of an FDA-approved pharmacologic agent is indicated. Finally, if the patient does not respond to the initial medication, the appropriate next step is to transition to a medication from a different pharmacologic class or perform a comprehensive reassessment for underlying occult conditions.

Step-by-Step Solution

1
Establish a clinical baseline and identify maladaptive behaviors.
Instruct the patient to keep a 1-to-2 week sleep diary.
To accurately calculate baseline sleep efficiency and document the exact discrepancy between time in bed and total sleep time, which is required to tailor behavioral interventions.
2
Initiate first-line definitive non-pharmacologic therapy.
Implement Cognitive Behavioral Therapy for Insomnia (CBT-I).
Current guidelines mandate CBT-I (including stimulus control and sleep restriction) as the first-line treatment for chronic insomnia disorder due to its sustained efficacy and lack of adverse drug effects.
3
Escalate to pharmacotherapy for refractory symptoms.
Trial an FDA-approved insomnia medication (e.g., suvorexant, zolpidem).
Medications are indicated strictly as a second-line intervention when CBT-I alone does not achieve clinical remission or is completely inaccessible to the patient.
4
Manage primary pharmacotherapy failure.
Switch to an alternative medication class or perform a psychiatric reassessment.
Refractory insomnia requires targeting a different neurochemical pathway (e.g., histamine via doxepin) and re-evaluating to ensure secondary causes of insomnia are not being missed.

Key Concept

Stepped-care diagnostic and management pathway for Chronic Insomnia Disorder

Alternative Method

While CBT-I is the gold standard, in clinical settings where certified CBT-I providers are completely unavailable, primary care physicians may utilize abbreviated behavioral interventions (Brief Behavioral Treatment for Insomnia - BBTI) alongside digital CBT-I applications as an alternative bridging step before resorting to pharmacotherapy.
Estimated Time:2m 0s
Question 590Question →

A 21-year-old man is brought to the psychiatrist by his parents for a follow-up appointment. Eight weeks ago, the patient was a passenger in a severe motor vehicle collision in which he sustained minor physical injuries. One week after the accident (seven weeks ago), he abruptly began hearing unfamiliar voices conversing about his actions and developed the belief that local traffic lights were sending him coded government messages. He exhibited grossly disorganized behavior, prompting hospitalization. He was started on oral risperidone, and his parents report that his hallucinations and delusions completely resolved three weeks ago. However, since his positive symptoms ceased, he has remained socially withdrawn, speaks only in rare monosyllables, and exhibits a strikingly flat affect. He has not returned to his college classes or his part-time job, and spends most of his day staring blankly out the window. His physical examination and vital signs are unremarkable. A urine toxicology screen is negative. Which of the following is the most accurate diagnosis for this patient at this time?

Show answer & explanation

Answer: Schizophreniform disorder

Answer

Schizophreniform disorder
The correct diagnosis is schizophreniform disorder because the total duration of the patient's illness is greater than 1 month but less than 6 months. When diagnosing schizophrenia-spectrum disorders, the timeline must account for the prodromal phase, the active phase (florid psychosis), and the residual phase. This patient had 4 weeks of active positive symptoms followed by 3 weeks of residual negative symptoms (alogia, avolition, flat affect), bringing the total continuous illness duration to 7 weeks.

Step-by-Step Solution

1
Identify the onset and nature of the initial symptoms.
The patient developed positive psychotic symptoms (auditory hallucinations, delusions, disorganized behavior) 7 weeks ago.
Establishing the exact onset is required for diagnostic timeline criteria.
2
Determine the current clinical status and presence of ongoing symptoms.
Positive symptoms resolved 3 weeks ago, but negative symptoms (flat affect, alogia, avolition) and functional impairment have persisted for the last 3 weeks.
Residual negative symptoms count toward the total continuous duration of a psychotic illness.
3
Calculate the total continuous duration of the psychiatric disturbance.
4 weeks of active positive symptoms + 3 weeks of ongoing residual negative symptoms = 7 weeks total duration.
Psychiatric diagnoses in the schizophrenia spectrum are strictly delineated by total illness duration.
4
Apply DSM-5 duration criteria to determine the correct diagnosis.
The illness has lasted > 1 month but < 6 months, fitting the criteria for schizophreniform disorder.
Brief psychotic disorder is < 1 month with full recovery, and schizophrenia requires >= 6 months.

Key Concept

The total duration of a psychotic illness includes prodromal, active, and residual phases (such as ongoing negative symptoms). An episode lasting between 1 and 6 months is diagnosed as schizophreniform disorder, even if positive symptoms have resolved.
Question 591Question →

Match each clinical presentation to the most appropriate psychiatric or behavioral diagnosis on the somatic symptom spectrum.

Click a left item, then click its matching right item

Items

A 32-year-old phlebotomist is admitted for her third episode of polymicrobial bacteremia this year. Blood cultures grow both skin and enteric flora. She has a central venous catheter, and nurses note her dressing is frequently tampered with. Despite the severe infections, she is remarkably cooperative, pleasant, and eager for further invasive procedures.
A 26-year-old man develops sudden-onset bilateral lower extremity paralysis immediately following a traumatic divorce proceeding. Neurological examination reveals intact deep tendon reflexes, normal muscle bulk, and a positive Hoover sign. He appears surprisingly unconcerned about his sudden inability to walk.
A 45-year-old executive visits various specialists weekly, convinced he has early-onset Alzheimer disease because he occasionally forgets minor details. He has no other cognitive or physical symptoms, but spends hours nightly researching dementia online, remaining highly anxious despite multiple normal comprehensive neurological and neuropsychological evaluations.
A 42-year-old warehouse worker presents with complaints of debilitating, diffuse back pain after a minor slip at work six months ago. He exhibits marked pain behaviors in the clinic, refuses physical therapy, and demands permanent disability documentation. However, independent surveillance video shows him effortlessly lifting heavy boxes into his truck.
A 50-year-old woman has a 10-year history of chronic pelvic pain, migrating polyarthralgias, and diffuse abdominal discomfort. She has undergone three negative laparoscopies and countless imaging studies. She constantly worries about the severity of her symptoms, and her perceived medical frailty has led her to quit her job and isolate herself at home.

Matches

Show answer & explanation

Answer

The correct matches differentiate the psychiatric conditions based on intentionality of symptom production, underlying motivation (internal vs. external), and the presence versus absence of prominent somatic symptoms.
Each clinical vignette provides pathognomonic features for a distinct condition on the somatic symptom spectrum. Proper classification relies on identifying symptom intentionality, motivating factors, and symptom severity.

Step-by-Step Solution

1
Evaluate the first presentation for intentional symptom production and motivation.
The tampered catheter and polymicrobial infections indicate intentional self-harm. The lack of external reward and eagerness for procedures point to an internal motivation (sick role), confirming factitious disorder.
Differentiating intentional versus unintentional symptom production is the primary branch point in this diagnostic algorithm.
2
Evaluate the second presentation for objective neurological compatibility.
The sudden paralysis with a positive Hoover sign indicates the symptom is not caused by structural neurological disease, confirming conversion disorder.
Conversion disorder requires clinical evidence of incompatibility with neurological disease.
3
Compare the third and fifth presentations regarding the actual burden of physical symptoms.
The third patient has severe anxiety but virtually no somatic symptoms (illness anxiety disorder). The fifth patient has significant, chronic physical pains causing distress (somatic symptom disorder).
The defining distinction between these two closely related disorders is whether significant somatic symptoms are actually present.
4
Evaluate the fourth presentation for external incentives.
The marked discrepancy between reported disability and observed functional capacity, combined with the demand for disability paperwork, confirms malingering.
Identifying concrete, external secondary gain is essential to correctly diagnose malingering.

Key Concept

Differential diagnosis of somatic symptom and related disorders requires evaluating three core dimensions: 1) Are the symptoms intentionally produced? 2) Is the motivation internal (sick role) or external (secondary gain)? 3) Are prominent physical symptoms present, or is the distress purely driven by disease-related anxiety?
Question 592Question →

A 47-year-old male accountant presents to an outpatient psychiatric clinic with a 3-month history of pervasive sadness, anhedonia, terminal insomnia, profound fatigue, impaired concentration, and a 12-lb (5.4 kg) weight loss. He is diagnosed with a severe episode of major depressive disorder without psychotic features. Over the next 14 months, his condition proves remarkably difficult to treat, eventually culminating in a hospitalization for depressive stupor and mood-congruent delusions.

Arrange the following therapeutic interventions in the most appropriate chronological sequence according to standard stepped-care escalation algorithms for major depressive disorder.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for the stepped-care management of major depressive disorder is: 1) Initiation of an SSRI, 2) Cross-tapering to an SNRI after monotherapy failure, 3) Augmentation with a second-generation antipsychotic after multiple monotherapy failures, and 4) Electroconvulsive therapy for treatment-refractory depression with the emergence of psychotic features.
Stepped-care for major depressive disorder begins with a single first-line agent, typically an SSRI. If this fails, the next step is switching to an alternative monotherapy, such as an SNRI or an atypical antidepressant (e.g., bupropion). If the patient remains resistant after multiple monotherapy trials, augmentation strategies are employed (e.g., adding a second-generation antipsychotic, lithium, or T3). Finally, for severe treatment-resistant depression—or when life-threatening complications like depressive stupor or psychotic features arise—electroconvulsive therapy (ECT) becomes the treatment of choice.

Step-by-Step Solution

1
Identify the standard first-line treatment for a new diagnosis of major depressive disorder.
Initiation of an SSRI (citalopram) is placed first in the sequence.
SSRIs have a favorable side-effect profile and are the gold standard for initial outpatient management.
2
Determine the next step when the initial first-line therapy fails to produce remission.
Cross-tapering to an SNRI (duloxetine) is placed second.
Switching monotherapies within or across classes is generally preferred before moving to polypharmacy in order to minimize medication burden.
3
Determine the strategy for a patient who has now failed multiple trials of monotherapy.
Augmentation therapy with a second-generation antipsychotic (aripiprazole) is placed third.
Once multiple monotherapies have failed, adding an augmenting agent is the next evidence-based step for treatment-resistant depression.
4
Identify the ultimate intervention for highly refractory disease, especially when complicated by psychosis or stupor.
Electroconvulsive therapy (ECT) is placed last in the sequence.
The patient eventually developed depressive stupor and mood-congruent delusions, which are primary indications for ECT in severe, refractory cases.

Key Concept

Stepped-care escalation for treatment-resistant major depressive disorder
Estimated Time:1m 0s
Question 593Question →

A high school student is transported to the acute care clinic by her family following a fainting spell. She reports eating less than 500 calories daily for several months. Her current body mass index is 13.8 kg/m213.8 \text{ kg/m}^2. Triage vitals reveal marked hypotension (80/50 mm Hg80/50 \text{ mm Hg}), profound sinus bradycardia (36/min36/\text{min}), and hypothermia (35.4∘C35.4^\circ\text{C}). Examination shows marked cachexia, temporal wasting, and lanugo. Arrange the following steps in the most appropriate chronological sequence for the comprehensive management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Perform initial EKG and baseline labs, 2) Admit to an inpatient medical unit, 3) Initiate conservative caloric reintroduction, 4) Transition to a residential eating disorder program.
The comprehensive management of severe anorexia nervosa follows a strict sequence prioritizing immediate life-saving medical stabilization before long-term psychiatric care. This patient presents in extremis with profound bradycardia, hypotension, and a BMI of 13.8. The immediate first step is an EKG and baseline labs to assess cardiac risk and electrolyte status. Because she exhibits marked vital sign instability, she must be admitted to a medical inpatient unit for continuous monitoring. Once admitted, conservative nutritional rehabilitation is initiated slowly to prevent refeeding syndrome. Finally, once medically stable, she can be safely transferred to a psychiatric facility for necessary psychotherapy.

Step-by-Step Solution

1
Identify the need for immediate emergency workup due to critical vital signs.
Order an EKG and baseline electrolytes.
Profound bradycardia and malnutrition carry a high risk of fatal arrhythmias and electrolyte derangements.
2
Determine the appropriate level of care based on the patient's instability.
Admit to a medical inpatient unit.
Patients with a heart rate below 40/min, severe hypotension, or BMI less than 15 require continuous telemetry and medical stabilization prior to psychiatric admission.
3
Plan the nutritional intervention safely.
Start cautious refeeding with daily lab monitoring.
Aggressive feeding can cause a sudden insulin spike, driving phosphorus, potassium, and magnesium intracellularly and triggering fatal refeeding syndrome.
4
Determine long-term management after the acute medical crisis resolves.
Transfer to a psychiatric or residential eating disorder facility.
Once the physical threat to life is resolved, the underlying psychiatric condition must be treated with specialized long-term psychotherapy.

Key Concept

Management sequence of severe anorexia nervosa: emergency medical workup, inpatient medical stabilization, cautious nutritional rehabilitation, followed by psychiatric transfer.
Estimated Time:1m 30s
Question 594Question →

A 2727-year-old man is brought to the emergency department by his sister due to increasingly bizarre behavior over the past 66 weeks. The sister reports that he has been barring the doors to their apartment, claiming that intelligence agencies have placed listening devices in the walls. He has also been talking to himself and appears to be responding to unseen stimuli. Over the past three days, he has not slept. He has no prior psychiatric history. His temperature is 37.7∘C37.7^\circ\text{C} (99.9∘F99.9^\circ\text{F}), pulse is 118/min118/\text{min}, and blood pressure is 152/94 mm Hg152/94\text{ mm Hg}. Physical examination reveals a thin, disheveled man. He is diaphoretic and has prominent dental caries along with multiple healing excoriations on his bilateral forearms and face. He is hypervigilant and frequently paces the room. Which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Substance-induced psychotic disorder

Answer

Substance-induced psychotic disorder
The correct answer accurately identifies that this patient's psychosis is a direct physiological consequence of substance abuse. Although the patient's severe paranoia and auditory hallucinations represent a psychotic state, the physical examination provides critical clues pointing to an underlying etiology. The combination of marked sympathetic hyperactivity (tachycardia, hypertension, diaphoresis), severe dental caries ('meth mouth' due to bruxism and decreased saliva production), and healing skin excoriations (resulting from delusional parasitosis, or 'meth bugs') is highly characteristic of chronic methamphetamine abuse. According to diagnostic criteria, a primary psychiatric diagnosis can only be made if the condition is not attributable to the physiological effects of a substance.

Step-by-Step Solution

1
Identify the primary psychiatric syndrome.
The patient presents with auditory hallucinations, delusions of persecution, and severe agitation, establishing a psychotic state.
Characterizing the core symptoms focuses the differential diagnosis on primary psychotic disorders versus secondary etiologies.
2
Evaluate the timeline of the symptoms.
The symptoms have been present for 66 weeks.
In the absence of secondary causes, a 66-week duration of psychosis points toward schizophreniform disorder (which spans 11 to 66 months).
3
Analyze the physical examination and vital signs for secondary causes.
The patient has marked sympathetic overactivity (tachycardia, hypertension, diaphoresis), decreased need for sleep, extensive dental caries, and skin excoriations.
These physical findings strongly indicate chronic methamphetamine intoxication (meth mouth, tactile hallucinations leading to excoriations).
4
Synthesize the diagnostic criteria.
Because the psychotic symptoms occur in the context of physiological evidence of substance abuse, primary psychiatric diagnoses are excluded.
DSM-5 diagnostic criteria for primary psychotic disorders strictly require that symptoms are not attributable to the physiological effects of a substance.

Key Concept

Differentiating primary psychotic disorders from substance-induced psychotic disorders based on physical examination findings.
Estimated Time:1m 30s
Question 595Question →

Pair the following clinical presentations with the most likely corresponding neurocognitive disorder.

Click a left item, then click its matching right item

Items

A 67-year-old executive exhibits new-onset apathy, declining personal hygiene, and inappropriately sexually suggestive comments to staff, with relatively preserved memory and visuospatial skills.
A 71-year-old mechanic develops recurrent, detailed visual hallucinations of animals, fluctuating periods of profound confusion, and a rigid, slow, shuffling gait.
A 76-year-old retired nurse presents with a broad-based, magnetic gait, new-onset involuntary leakage of urine, and recent psychomotor retardation with cognitive slowing.
A 69-year-old accountant with poorly controlled hypertension shows a sudden, stepwise decline in executive function three months after an episode of transient right-sided weakness.

Matches

Show answer & explanation

Answer

The presentations map respectively to frontotemporal dementia (early behavior changes and disinhibition), dementia with Lewy bodies (visual hallucinations and parkinsonism), normal pressure hydrocephalus (classic triad of gait disturbance, incontinence, and dementia), and vascular dementia (stepwise decline following a cerebrovascular event).
Each clinical presentation contains classic pathognomonic features that align with specific diagnostic criteria for the major neurocognitive disorders, allowing clear differentiation between them.

Step-by-Step Solution

1
Analyze the 67-year-old executive's presentation.
Identified early behavioral changes, disinhibition, and preserved memory.
These features distinguish behavioral variant frontotemporal dementia from Alzheimer disease, where memory loss is typically the first prominent symptom.
2
Evaluate the 71-year-old mechanic's symptoms.
Noted recurrent visual hallucinations, cognitive fluctuations, and parkinsonism.
This specific clinical triad forms the core diagnostic criteria for dementia with Lewy bodies.
3
Assess the 76-year-old retired nurse's clinical signs.
Recognized the triad of magnetic gait, incontinence, and cognitive decline.
This triad is classic for normal pressure hydrocephalus and indicates a potentially reversible cause of dementia.
4
Review the 69-year-old accountant's history.
Correlated the stepwise cognitive decline with a history of hypertension and a prior transient ischemic attack.
A sudden onset and stepwise progression of cognitive impairment following focal neurologic deficits point to vascular neurocognitive disorder.

Key Concept

Differential diagnosis of major neurocognitive disorders based on core clinical criteria and timeline of symptom onset.
Question 596Question →

A 28-year-old man with a known history of schizophrenia is brought to the emergency department by police due to severe agitation. He is pacing rapidly in the evaluation room, shouting at unseen stimuli, and intermittently clenching his fists. When nursing staff approach, he yells, 'Stay away from me, you are trying to poison me!' Arrange the following management steps in the most appropriate, evidence-based escalating sequence for addressing this patient's acute agitation, from the initial preferred approach to the intervention of last resort.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct escalating sequence for managing acute agitation is: 1) Verbal de-escalation, 2) Voluntary oral medications, 3) Involuntary intramuscular medications, and 4) Physical restraints as a last resort.
The standard of care for managing acute psychiatric agitation in the emergency setting follows the principle of utilizing the least restrictive intervention necessary. According to consensus guidelines (e.g., Project BETA), unless a patient is actively violent, verbal de-escalation and environmental calming must be the initial approach. If this is ineffective, offering voluntary oral medications (such as a first- or second-generation antipsychotic, often combined with a benzodiazepine) is the preferred pharmacological step. Oral administration preserves patient autonomy and is far less traumatic than parenteral administration. If the patient refuses oral medications and poses an imminent threat to themselves or staff, involuntary intramuscular (IM) medications (chemical restraint) are then utilized. Physical restraints are strictly the intervention of last resort due to the high risk of physical injury, rhabdomyolysis, and psychological trauma, and they should only be implemented when verbal and chemical interventions fail to prevent immediate harm.

Step-by-Step Solution

1
Assess the patient's current level of agitation and imminent risk of violence.
The patient is highly agitated, pacing, and paranoid, but is not actively engaged in physical violence.
Risk assessment determines whether verbal de-escalation is safe to attempt or if immediate physical/chemical restraint is strictly necessary.
2
Select the least restrictive initial intervention.
Verbal de-escalation and environmental modification are prioritized as the first step.
Maintaining the therapeutic alliance and avoiding coercive measures are paramount when patient and staff safety are not immediately compromised.
3
Determine the optimal route for pharmacological intervention if verbal de-escalation fails.
Voluntary oral medications are offered as the first-line pharmacological step.
Oral medications respect patient autonomy, have a similar onset to IM forms when given appropriately, and avoid the trauma of forced injections.
4
Identify the indications for involuntary measures.
Intramuscular chemical restraint is used next, followed by physical restraints only as an absolute last resort.
Involuntary interventions are reserved for when the patient poses an imminent threat and refuses less restrictive options. Physical restraints carry the highest risk of morbidity and mortality.

Key Concept

Stepwise management of acute psychiatric agitation prioritizing the least restrictive interventions.
Estimated Time:1m 30s
Question 597Question →

A 7-year-old girl is brought to the pediatric clinic by her parents at the recommendation of her second-grade teacher. Over the past four months, the teacher has noted that the patient frequently "zones out" during reading and math groups. During these episodes, she stares blankly at the wall for several minutes and fails to complete her assignments. Her desk is highly disorganized, and she frequently loses her school supplies. When the teacher loudly calls her name during one of these staring episodes, she startles, immediately apologizes, and asks for the instructions to be repeated. At home, she takes hours to complete brief homework assignments, frequently misplaces her jacket, and struggles to follow multi-step commands such as "brush your teeth, put on your pajamas, and pick out a book." There is no history of lip smacking, eyelid fluttering, or sudden loss of postural tone. Her physical and neurologic examinations are unremarkable. Which of the following clinical features is most specific for distinguishing this patient's most likely underlying disorder from childhood absence epilepsy?

Show answer & explanation

Answer: The staring episodes can be abruptly terminated by tactile or verbal stimuli

Answer

The distinguishing feature is that the staring episodes can be abruptly terminated by tactile or verbal stimuli, indicating daydreaming rather than an active seizure.
The correct answer accurately identifies that staring episodes due to severe inattention (daydreaming in ADHD) can be readily interrupted by a loud voice or a physical touch. In contrast, childhood absence epilepsy involves generalized 3-Hz spike-and-wave cortical discharges that render the patient completely unresponsive to external tactile or verbal stimuli during the seizure. Because this patient can be redirected out of her spell by her teacher, her presentation is diagnostic of ADHD rather than epilepsy.

Step-by-Step Solution

1
Analyze the clinical presentation and identify the primary differential diagnosis.
The patient presents with staring spells, severe disorganization, and failure to follow multi-step commands in two settings (home and school). The primary differential is between Attention-Deficit/Hyperactivity Disorder (ADHD, predominantly inattentive presentation) and Childhood Absence Epilepsy.
Both conditions frequently present in early school-aged children with academic decline and "zoning out" in class.
2
Evaluate the clinical characteristics of the staring spells described in the vignette.
The episodes last several minutes, lack automatisms (no lip smacking or eyelid fluttering), and the patient immediately startles and responds when her name is called loudly.
Detailed phenomenology of the event is required to separate a behavioral/attentional lapse from a neurological event.
3
Differentiate based on pathophysiology and unresponsiveness.
Absence seizures are 10-20 second generalized cortical discharges during which the patient is unconscious and cannot be interrupted. ADHD staring is severe inattention that can be immediately broken by external tactile or verbal stimuli.
Identifying the interruptibility of the spell accurately diagnoses ADHD and rules out a primary seizure disorder prior to ordering an EEG.

Key Concept

Differentiating ADHD (inattentive presentation) from Childhood Absence Epilepsy based on the interruptibility of staring spells.
Question 598Question →

Match each patient's clinical presentation of a psychotropic medication adverse effect to the primary pharmacodynamic or pathophysiologic mechanism responsible for the finding.

Click a left item, then click its matching right item

Items

A patient on maintenance therapy for bipolar I disorder presents with excessive thirst and frequent urination; urine osmolality is 150 mOsm/kg and does not increase following a water deprivation test.
A young male given an intramuscular injection for acute agitation suddenly develops a painful, sustained upward deviation of the eyes and extreme cervical muscle contraction.
A patient treated for refractory schizophrenia develops severe, socially embarrassing drooling (sialorrhea) concurrent with paradoxical complaints of blurred vision and severe constipation.
A patient receiving an augmenting agent for depression with insomnia exhibits significant daytime somnolence and a 6-kg weight gain in a month, while explicitly denying any sexual dysfunction.
A patient recently transitioned to a new long-acting injectable antipsychotic develops bilateral breast discharge, secondary amenorrhea, and early osteopenia.

Matches

Show answer & explanation

Answer

The correct matches require linking the clinical phenotype of the adverse effect to its exact molecular neuropharmacologic mechanism, such as linking clozapine's sialorrhea to M4 agonism, and lithium's polyuria to V2 receptor adenylyl cyclase interference.
Each pair correctly links a highly specific clinical adverse effect to its precise molecular mechanism. Lithium causes nephrogenic diabetes insipidus via V2 receptor interference. High-potency typicals cause dystonia via nigrostriatal D2 blockade. Clozapine causes sialorrhea via M4 agonism despite other anticholinergic effects. Mirtazapine causes weight gain and sedation via H1 and 5-HT2C antagonism. Risperidone causes hyperprolactinemia via tuberoinfundibular D2 blockade.

Step-by-Step Solution

1
Identify the underlying medication and clinical syndrome for each presentation.
Presentations map to Lithium (nephrogenic diabetes insipidus), High-potency typical antipsychotics (acute dystonia), Clozapine (sialorrhea/anticholinergic paradox), Mirtazapine (sedation/weight gain), and Risperidone/Paliperidone (hyperprolactinemia).
Accurate syndrome identification is required before molecular mechanisms can be mapped.
2
Correlate each identified medication/syndrome with its primary receptor binding profile or molecular target.
Lithium maps to V2/adenylyl cyclase interference; Dystonia to Nigrostriatal D2 blockade; Clozapine sialorrhea to M4 agonism; Mirtazapine to H1/5-HT2C antagonism; Hyperprolactinemia to Tuberoinfundibular D2 blockade.
USMLE Step 2 requires second- and third-order reasoning to connect clinical phenotypes directly to pharmacodynamics.

Key Concept

Pharmacodynamic mechanisms of psychotropic medication adverse effects
Estimated Time:2m 0s
Question 599Question →

A metropolitan toxicology service is evaluating several patients with suspected substance use disorders. Correlate the following distinct clinical manifestations with their correct underlying etiology.

Click a left item, then click its matching right item

Items

Rotatory nystagmus, impulsivity, ataxia, and diminished pain perception resulting in combative behavior.
Severe dysphoria, vivid and unpleasant dreams, hypersomnolence, increased appetite, and psychomotor retardation.
Diaphoresis, bruxism, hyperthermia, and confusion complicated by new-onset generalized seizures and hyponatremia.
Mydriasis, piloerection, rhinorrhea, excessive yawning, and diffuse myalgias in an alert and highly distressed patient.
Global confusion, prominent visual hallucinations, resting tremor, and autonomic hyperactivity peaking on hospital day 3.

Matches

Show answer & explanation

Answer

Phencyclidine (PCP) intoxication matches rotatory nystagmus and combativeness. Cocaine withdrawal matches hypersomnolence, hyperphagia, and vivid dreams. MDMA intoxication matches bruxism, hyperthermia, and hyponatremia. Opioid withdrawal matches piloerection, yawning, and myalgias. Severe alcohol withdrawal matches day 3 delirium and autonomic hyperactivity.
Each substance toxidrome has distinct hallmark features. PCP involves nystagmus and analgesia; cocaine withdrawal involves a depressive 'crash' with hyperphagia and hypersomnolence; MDMA toxicity uniquely causes bruxism and SIADH leading to hyponatremia; opioid withdrawal presents with yawning, piloerection, and myalgias with an intact sensorium; and severe alcohol withdrawal (delirium tremens) features late-onset confusion, hallucinations, and autonomic hyperactivity.

Step-by-Step Solution

1
Analyze the first clinical presentation.
Rotatory nystagmus and analgesia are identified.
These are the hallmark pathognomonic signs of PCP intoxication, distinguishing it from other hallucinogens and stimulants.
2
Analyze the second presentation focusing on behavioral and sleep changes.
The combination of hypersomnolence, increased appetite, and vivid dreams is recognized as a 'crash' state.
This is characteristic of stimulant (e.g., cocaine) withdrawal, which causes neuro-depressive symptoms without significant physical autonomic signs.
3
Evaluate the third presentation noting the specific complications.
Bruxism, hyperthermia, and hyponatremia-induced seizures point directly to MDMA.
MDMA increases serotonin, dopamine, and norepinephrine, and uniquely triggers ADH release leading to severe dilutional hyponatremia.
4
Assess the fourth presentation for classic withdrawal signs.
Piloerection, mydriasis, and yawning in an alert patient indicate opioid withdrawal.
Opioid withdrawal mimics a severe viral prodrome with sympathetic overactivity but crucially does not cause delirium or altered mental status.
5
Review the timeline and symptoms of the fifth presentation.
Delirium and visual hallucinations peaking at 72 hours indicate delirium tremens.
The severe alcohol withdrawal timeline perfectly aligns with these late-stage, life-threatening autonomic and psychotic symptoms.

Key Concept

Differentiation of substance-induced toxidromes and withdrawal syndromes based on unique physical exam findings, such as nystagmus in PCP, hyponatremia in MDMA, and piloerection in opioid withdrawal.
Question 600Question →

A 52-year-old woman comes to the primary care clinic for evaluation of sleep disturbance and leg discomfort over the past 3 months. She describes a deep, "crawling" sensation in her calves and thighs that begins almost exclusively when she lies down in bed or relaxes on the couch in the evening. The sensation is accompanied by an irresistible urge to move her legs, and she must pace the hallway for several minutes to find temporary relief. She has no symptoms during the day and sits calmly throughout the examination. Her medical history is significant for bipolar I disorder, hyperlipidemia, and uterine leiomyomas causing heavy menstrual bleeding. Current medications include lithium, lurasidone, and atorvastatin. Vital signs are normal. Neurological examination shows no resting tremor, rigidity, or focal deficits. Laboratory testing reveals a hemoglobin of 11.2 g/dL11.2 \text{ g/dL}, mean corpuscular volume of 76 fL76 \text{ fL}, and serum ferritin of 18 ng/mL18 \text{ ng/mL} (Normal: 15−200 ng/mL15-200 \text{ ng/mL}). Which of the following is the most appropriate next step in the management of this patient's sleep-related symptoms?

Show answer & explanation

Answer: Oral ferrous sulfate

Answer

Oral ferrous sulfate
The correct answer is oral ferrous sulfate. This patient's clinical presentation meets the four core diagnostic criteria for Restless Legs Syndrome (RLS): an urge to move the legs, worsening of symptoms during periods of rest or inactivity, partial or total relief with movement, and worsening of symptoms in the evening or night. RLS can be primary (idiopathic) or secondary to other conditions, with iron deficiency being one of the most common and reversible secondary causes. This patient's history of heavy menstrual bleeding and her laboratory results (microcytic anemia with a serum ferritin of 18 ng/mL18 \text{ ng/mL}) confirm iron deficiency. Current clinical guidelines state that for patients with RLS and a fasting serum ferritin level below 75 ng/mL75 \text{ ng/mL}, oral iron supplementation is the most appropriate first-line treatment. Symptomatic pharmacotherapy is generally reserved for patients with normal iron stores or those whose symptoms persist after adequate iron replacement.

Step-by-Step Solution

1
Analyze the clinical presentation to identify the primary syndrome.
The patient describes an urge to move the legs, worsening at rest, relief with movement, and evening predominance, which fulfills the diagnostic criteria for Restless Legs Syndrome (RLS).
Accurate diagnosis relies on recognizing the four core clinical features of RLS (the URGE criteria).
2
Differentiate the symptoms from medication-induced side effects.
The lack of daytime restlessness and the prominent circadian pattern distinguish her symptoms from akathisia, an adverse effect of her lurasidone therapy.
Antipsychotic-induced akathisia typically presents as a constant, non-circadian inner restlessness, which requires a different management strategy.
3
Identify secondary causes of the diagnosed syndrome.
The laboratory findings of microcytic anemia and low serum ferritin (18 ng/mL18 \text{ ng/mL}) indicate iron deficiency, a major reversible cause of RLS.
Current guidelines recommend evaluating iron stores in all patients presenting with RLS symptoms.
4
Select the most appropriate initial therapy based on the underlying etiology.
Oral iron supplementation is the indicated next step in management.
For patients with RLS and a serum ferritin level below 75 ng/mL75 \text{ ng/mL}, replenishing iron stores is the first-line treatment before initiating symptomatic pharmacotherapy.

Key Concept

Restless Legs Syndrome (RLS) is clinically diagnosed by an urge to move the legs that worsens at rest and in the evening, and improves with movement. First-line management involves checking a serum ferritin level and prescribing iron supplementation if ferritin is <75 ng/mL<75 \text{ ng/mL}.
PreviousPage 30 / 41Next
Psychiatry Practice Questions — USMLE Step 2 CK — Page 30 | Examkin